Sr. Seaman et al., MORTALITY FROM OVERDOSE AMONG INJECTING DRUG-USERS RECENTLY RELEASED FROM PRISON - DATABASE LINKAGE STUDY, BMJ. British medical journal, 316(7129), 1998, pp. 426-428
Objective: To assess whether injecting drug users have a higher than u
sual risk of death from overdose in the 2 weeks after release from pri
son. Design: Sounder coding of surnames and information on date of bir
th were used to link entry and release dates from the local prison bet
ween 1983 and 1994 with clinical data from Edinburgh City Hospital's c
ohort of male injecting drug users who are infected with HIV. Setting:
Edinburgh City Hospital and Edinburgh Prison. Subjects: 316/332 male
injecting drug users infected with HIV in the City Hospital HIV cohort
; 16 were excluded because they were enrolled after developing AIDS or
because their precise date of death was not available. Main outcome m
easure: Relative risk of dying from overdose before developing AIDS an
d relative risk of dying of all causes before developing AIDS during t
he 2 weeks after release from prison; this was compared with relative
risks of death during other time at liberty. Results: 238/316 (75%) in
jecting drug users served time in the prison between 1983 and 1994. 33
out of 316 injecting drug users who were infected with HIV died befor
e developing AIDS during 517 177 days at risk 20 of these men died of
an overdose; 6 of these deaths occurred within 2 weeks of release duri
ng 5903 days at risk Death rates from overdose before the development
of AIDS were 1.02/1000 days during the 2 weeks after release (recently
released) and 0.029/1000 days during other times of liberty. The rela
tive risk of death from overdose became 7.7 (1.5 to 39.1) after tempor
al matching (when the comparison was limited to the first 2 weeks afte
r release v the next 10 weeks). The crude relative risk in an analysis
combining stratified prison term and the 2 weeks after release was 4.
5 (1.7 to 11.7) for death from overdose. After temporal matching these
risks became 1.8 (0.4 to 9.2). Conclusion: Prisons should evaluate in
terventions to reduce the risk of death from overdose after release.